XTL Biopharmaceuticals Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 1.98 -0.04 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.02 | 52 Week High | $1.75 | |||
| Open | $2.02 | 52 Week Low | $0.64 | |||
| Day High | $2.05 | P/E | N/A | |||
| Day Low | $1.98 | EPS | $0.00 | |||
| Volume | 25,188 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 1.98 -0.04 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.02 | 52 Week High | $1.75 | |||
| Open | $2.02 | 52 Week Low | $0.64 | |||
| Day High | $2.05 | P/E | N/A | |||
| Day Low | $1.98 | EPS | $0.00 | |||
| Volume | 25,188 | |||||
